• Company
    • About Us
    • Our Journey
    • Our Team
    • Media Kit
    • Contact
  • Our Approach
    • How We Do It
    • Drug The Undruggable
  • Partners
    • Portfolio Companies
    • Biopharma Partnerships
    • Research Partnerships
    • Emerging Biotech Partnerships
    • AIMS Awards
  • Pipeline
    • R&D Pipeline
    • Co-Developed Pipeline
  • News & Events
    • In The News
    • Press Releases
    • Blog
    • Events
    • Publications
  • Careers
    • Careers
    • Life at Atomwise
    • Open Positions
  • Company
    • About Us
    • Our Journey
    • Our Team
    • Media Kit
    • Contact
  • Our Approach
    • How We Do It
    • Drug The Undruggable
  • Partners
    • Portfolio Companies
    • Biopharma Partnerships
    • Research Partnerships
    • Emerging Biotech Partnerships
    • AIMS Awards
  • Pipeline
    • R&D Pipeline
    • Co-Developed Pipeline
  • News & Events
    • In The News
    • Press Releases
    • Blog
    • Events
    • Publications
  • Careers
    • Careers
    • Life at Atomwise
    • Open Positions

  • Press Releases
  • Press Releases
Discovery of Novel Inhibitors of a Critical Brain Enzyme Using a Homology Model and a Deep Convolutional Neural Network

July 30, 2020

  • AI drug discovery
  • drug resistance

Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models
Small molecules block the interaction between porcine reproductive and respiratory syndrome virus and CD163 receptor and the infection of pig cells
  • Contact
  • Media Kit
  • How We Do It
  • Drug the Undruggable
  • Pipeline
  • Portfolio Companies
  • Biopharma Partnerships
  • Research Partnerships
  • Emerging Biotech Partnerships
  • AIMS Awards
  • In The News
  • Press Releases
  • Blog
  • Events
  • Publications
  • About Us
  • Our Journey
  • Our Team
  • Careers
  • Life At Atomwise
  • Open Positions
Privacy Policy
Copyright 2021 Atomwise Inc. All Rights Reserved